Clinical Trials Directory

Trials / Completed

CompletedNCT05327374

Use of ΔIVC for Early Diagnosis of AHF in AECOPD

Diagnosis of Acute Heart Failure in Chronic Obstructive Pulmonary Disease Exacerbation Using the Inferior Vena Cava Collapsibilty Index

Status
Completed
Phase
Study type
Observational
Enrollment
401 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.

Detailed description

Acute heart failure (AHF) is a common cause of COPD exacerbation however its role is very often underestimated. Until now, the use of echocardiography and some invasive hemodynamic exploration techniques such as the Swanganz catheter has been stated as reference. Other noninvasive diagnostic methods have been studied, such as systolic time intervals and Valsalva maneuver, but their application still difficult in patients with COPD exacerbation, especially in emergency department (ED) settings. the study aimed to evaluate the performance of a new diagnostic technique based on the measurement of the ΔIVC for the early identification of AHF in patients presenting to the ED with acute COPD exacerbation.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcalculation of the inferior vena cava collapsibility indexthe ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure

Timeline

Start date
2022-03-01
Primary completion
2022-11-30
Completion
2023-01-31
First posted
2022-04-14
Last updated
2023-05-16

Locations

3 sites across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT05327374. Inclusion in this directory is not an endorsement.